Skip to main content
. 2018 Jan 24;19(3):e44871. doi: 10.15252/embr.201744871
Che‐1 forward 5′‐CCGGAATTCGGATAAGACCAAACTGGCT‐3′
Che‐1 reverse 5′‐CCGCTCGAGGAGTTCTCGAAGGAGCTG‐3′
MLL1 forward 5′‐GACACATGGATGCAGACCAC‐3′
MLL1 reverse 5′‐CGGGCCAGGACTATCAGTAG‐3′
ANP32 forward 5′‐TCCGCCGCTAGCAAACCCTTC‐3′
ANP32 reverse 5′‐GGTCCGGTTCCTCAGCTCCAG‐3′
FOXM1 forward 5′‐CACCCCAGTGCCAACCGCTACTTG‐3′
FOXM1 reverse 5′‐AAAGAGGAGCTATCCCCTCCTCAG‐3′
CDK1 forward 5′‐GGAAGGGGTTCCTAGTACTGC‐3′
CDK1 reverse 5′‐TGGAATCCTGCATAAGCACA‐3′
Cyclin B1 forward 5′‐GTTCCTACGGCCCCTGCT‐3′
Cyclin B1 reverse 5′‐ATTTTGGCCTGCAGTTGTT‐3′
β‐actin forward 5′‐GACAGGATGCAGAAGGAGATTACT‐3′
β‐actin reverse 5′‐TGATCCACATCTGCTGGAAGGT‐3′